Successive case reports confirmed the beneficial effects of liraglutide in obese PsO patients without T2DM (52), and a subsequent trial demonstrated marked improvements in PsO symptoms within a few days of treatment, regardless of significant weight loss (50), a result which was later confirmed in other studies (53, 54)
The SURPASS program, which evaluated tirzepatide in patients with type 2 diabetes across diverse treatment settings, consistently showed superior reductions in glycated hemoglobin compared with established therapies, including basal insulin and selective GLP 1 receptor agonists
Kim points to a randomized trial in patients with alcohol use disorder: The number of drinking days didnt change, but people drank less on the days they did drink
Cortisol promotes visceral fat storage , raises insulin resistance, encourages quick-energy eating, and increases appetite for high-calorie foods
Research Overview Retatrutide is a next-generation multi-agonist peptide that engages GIP, GLP-1 and glucagon receptors simultaneously
This study aims to address this gap by evaluating the enhanced liver-protective effects of GGV, an innovative therapeutic formulation combining these 3 compounds